Pages that link to "Q26852807"
Jump to navigation
Jump to search
The following pages link to Pharmacogenetics and outcome with antipsychotic drugs (Q26852807):
Displaying 11 items.
- Pharmacogenetic testing revisited: 5' nuclease real-time polymerase chain reaction test panels for genotyping CYP2D6 and CYP2C19. (Q33597438) (← links)
- Pharmacogenetics in psychiatry: state of the art (Q49567721) (← links)
- Blood Gene Expression Profile Predicts Response to Antipsychotics. (Q55021168) (← links)
- Association study between COMT , DRD2 , and DRD3 gene variants and antipsychotic treatment response in Mexican patients with schizophrenia (Q59135101) (← links)
- Description of an Innovative Pediatric Individualized Therapeutics Clinic: Working toward Precision Drug Therapy (Q64104196) (← links)
- Treatment-Resistant Schizophrenia: Genetic and Neuroimaging Correlates (Q64108690) (← links)
- The effect of CYP2D6 variation on antipsychotic-induced hyperprolactinaemia: a systematic review and meta-analysis (Q89518813) (← links)
- The role of genetics and genomics in clinical psychiatry (Q90728372) (← links)
- Precise treatments for schizophrenia: where is the way forward? (Q90733110) (← links)
- A pharmacogenetic intervention for the improvement of the safety profile of antipsychotic treatments (Q92185882) (← links)
- Wikidata:Database reports/Constraint violations/P275 (← links | edit)